Morgan Stanley Maintains Equal-Weight on Johnson & Johnson, Raises Price Target to $175
Portfolio Pulse from Benzinga Newsdesk
Morgan Stanley has maintained its Equal-Weight rating on Johnson & Johnson while raising the price target from $169 to $175.
October 16, 2024 | 12:03 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Morgan Stanley has maintained its Equal-Weight rating on Johnson & Johnson and increased the price target from $169 to $175, indicating a positive outlook.
The increase in the price target from $169 to $175 by Morgan Stanley suggests a positive outlook for Johnson & Johnson, which could lead to a short-term increase in stock price. The maintained Equal-Weight rating indicates a balanced view, but the raised target reflects confidence in the company's performance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100